Intelligence Infrastructure

Data Sources

Vantro's market intelligence is built on primary source data from multilateral organisations, national regulatory authorities, and practitioner market analysis. Every market listed below names its primary regulatory and customs authorities and links directly to each one.

Multilateral Organisations
WHO Global Health Observatory ↗
Health system indicators, UHC coverage, disease burden data
World Bank Open Data ↗
GDP, healthcare expenditure, ease of doing business indicators
UNICEF Supply Division ↗
Procurement volumes, product categories, supplier and pricing data
UNDP Human Development Reports ↗
Market context and development indicators
WHO Prequalification Programme ↗
Prequalified product lists, assessment timelines, supplier data
Global Fund Procurement Data ↗
Country programme procurement data, eligible product categories
GAVI Supply and Procurement ↗
Vaccine procurement structures and co-financing models
UNCTAD TRAINS ↗
Tariff and non-tariff measure data for customs analysis
Registration Registers — Ingest Status

Vantro ingests these registers into its own store on a schedule and checks a product against the stored copy, never by calling the authority at brief time. A brief only reports a registration check when the relevant ingest below succeeded within 14 days. When it did not, the brief says the check was not made rather than reporting no registration found.

CDSCO medical device & IVD register (India) ↗not yet ingested — checks suspended
Import and manufacturing licences. Device name, brand, model, risk class, licence number, issue date, licence holder.
CDSCO approved new drugs & FDC lists (India) ↗not yet ingested — checks suspended
Published year-slice lists. Molecule, indication and approval date only — these lists carry no brand name and no applicant name, so they can establish that a molecule is approved and nothing about who holds a registration of it.
National Regulatory & Customs Authorities
CountryRegulatory AuthorityCustoms / Revenue Authority
Saudi Arabia
SFDA ↗
Device & drug registration, CE/510(k) reliance, NUPCO procurement
UAE
MOHAP ↗
Registration, classification, DHA/HAAD free zone rules
Qatar
MOPH Qatar ↗
Registration, pricing, Hamad Medical procurement
Kuwait
MOPH Kuwait ↗
Registration requirements, public procurement channels
Jordan
JFDA ↗
Registration, CE reliance, pricing controls
Turkey
TITCK ↗
Device registration, SGK reimbursement, local partner rules
Egypt
EDA ↗
Device registration, pricing controls, CE reliance partial
Morocco
DMP / MoH ↗
Registration, EMA/CE reliance, SEGMA procurement
Kenya
PPB Kenya ↗
Device registration, WHO CRP pathway, KEMSA procurement
Nigeria
NAFDAC ↗
Registration 12–24mo, WHO PQ for public sector, local content rules
South Africa
SAHPRA ↗
CE/EU MDR reliance pathways, Section 21 authorisation
Ghana
FDA Ghana ↗
Device & drug registration, CE reliance, procurement pathways
Ethiopia
EFDA ↗
Registration requirements, public procurement channels
Tanzania
TMDA ↗
6–12mo registration, MSD procurement, USAID/Global Fund channels
Rwanda
Rwanda FDA ↗
3–6mo for WHO-PQ products, RMS procurement
Senegal
DPM / DPMED ↗
CAMICS procurement, UEMOA reliance pathway
Uganda
NDA Uganda ↗
Device registration, NMS procurement, EAC reliance
Zambia
ZAMRA ↗
Device & drug registration, Medical Stores procurement
Côte d'Ivoire
DGPHP / WAEMU ↗
Registration, UEMOA reliance, PNSP procurement
India
CDSCO ↗
Medical device rules 2017, NPPA price controls, UNICEF channel
Bangladesh
DGDA ↗
Device & drug registration, CMSD procurement
Pakistan
DRAP ↗
Device registration, pricing controls, PPHI procurement
Nepal
DoDA Nepal ↗
Registration requirements, public procurement channels
Bhutan
DRA Bhutan ↗
Device & drug registration, Essential Medicines procurement
Vietnam
DAV / MOH ↗
Registration classes, reliance pathways, class C/D backlog
Thailand
FDA Thailand ↗
Device classification, GPO procurement, CE reliance
Indonesia
BPOM ↗
Device/drug registration, halal cert, complex geography
Philippines
FDA Philippines ↗
Registration, CE reliance, PhilHealth/JKN procurement
China
NMPA ↗
Class III 12–18mo, VBP procurement, local JV often required
Brazil
ANVISA ↗
Sanitary registration, SUS procurement, Mercosur reliance
Mexico
COFEPRIS ↗
Registration, IMSS/ISSSTE tenders, local partner required
Colombia
INVIMA ↗
Device & drug registration, SGSSS procurement
Peru
DIGEMID ↗
Registration, SIS procurement, CE reliance partial
Argentina
ANMAT ↗
Device registration, PAMI/Obras Sociales procurement
Chile
ISP ↗
Registration, CENABAST procurement, CE reliance
Canada
Health Canada ↗
Class II 90-day review, MRA reliance for FDA-cleared devices
European Union
EMA / National CAs ↗
CE Mark EU MDR 2017/745, notified body, IVDR for IVD
Market Intelligence

Procurement structure data, tender cycle timing, pricing framework analysis, and local partner requirement details are compiled by global health market access practitioners with direct experience working across these markets for WHO, UNICEF, Bloomberg Philanthropies, and the World Bank. Timeline estimates reflect that practitioner experience of real review durations rather than authority-published targets, which frequently understate actual processing time.

Data Limitations

Regulatory environments change frequently across international markets. Vantro makes every effort to maintain current, accurate data but cannot guarantee completeness or accuracy for all product categories in all markets. Users should treat Vantro dimension ratings as directional intelligence and engage qualified local regulatory consultants for formal market entry decisions.